Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Micron Shares Surge Following Triple Analyst Upgrade

Robert Sasse by Robert Sasse
September 19, 2025
in Analysis, Nasdaq, Semiconductors, Trading & Momentum
0
Micron Stock
0
SHARES
123
VIEWS
Share on FacebookShare on Twitter

A remarkable sequence of analyst upgrades within a 48-hour window has propelled Micron Technology’s stock, driving a powerful rally of over 5%. The memory chip specialist from Idaho is currently at the center of a wave of Wall Street optimism, a notable shift for an industry often characterized by cyclicality and uncertainty. The surge in confidence stems from a fundamental reassessment of the company’s prospects.

A Confluence of Bullish Sentiment

The catalyst for this reassessment began on September 17th, when Wolfe Research issued a surprisingly positive outlook. The firm’s analysts pointed to resilient DRAM pricing and emphasized that demand for NAND flash memory is strengthening due to a shortage of hard disk drives. Wolfe Research set a new price target of $180.

The momentum accelerated just one day later. Susquehanna adopted an even more bullish stance, significantly raising its price objective to $200. This aggressive target is underpinned by the expectation that prices for high-bandwidth memory (HBM) will remain robust through 2026, driven by the insatiable demands of rapidly expanding artificial intelligence infrastructure.

The trend culminated on September 18th with Wedbush aligning with the $200 valuation. In a particularly noteworthy move, the analysts based their valuation on a multiple of ten times Micron’s anticipated peak earnings for 2026, a figure they characterized as conservative.

The AI Engine of Growth

This wave of analyst action reflects a profound shift in Micron’s business fundamentals. The company’s data center division is experiencing robust year-over-year growth, fueled by its advanced memory solutions tailored for AI applications. Its strategic partnership with Nvidia is a key advantage, with its HBM chips integrated into the new Blackwell platform.

Should investors sell immediately? Or is it worth buying Micron?

Looking ahead, the potential is even greater. Micron is already conducting customer tests for its next-generation HBM4 chips, which promise a 60% increase in computational performance while consuming 20% less power.

The demand for AI is not confined to data centers. The proliferation of generative AI features in smartphones and PCs is also creating a substantial need for more advanced memory. Industry projections suggest generative AI smartphones could capture 70% of the market by 2029, typically requiring 50% more memory than standard devices.

Impending Financial Results

All eyes are now on Micron’s upcoming fourth-quarter earnings for fiscal 2025, scheduled for release on September 23rd. Expectations are exceptionally high. In August, the company already raised its revenue forecast by a substantial $500 million, guiding for $11.2 billion in sales. Its earnings-per-share estimate was also lifted, jumping from $2.50 to $2.85.

Should Micron meet these projections, it would represent a 45% surge in revenue. Even more impressive, its EPS could more than double compared to the previous year. For the full fiscal year 2025, some analysts are projecting earnings that could be ten times higher than those achieved in 2024.

Despite the stock’s impressive run—it has gained 79% since the start of the year—the valuation does not yet appear overextended. The shares trade at a price-to-earnings ratio of approximately 11, which remains significantly below the Nasdaq-100 average of 31.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from March 25 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Micron: Buy or sell? Read more here...

Tags: Micron
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Coeur Mining Stock
Analysis

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026
Next Post
Eli Lilly Stock

Eli Lilly's Strategic Expansion: A Dual-Pronged Investment Approach

UPS Stock

UPS Acquisition Deal Collapses Amid Sector-Wide Regulatory Pressures

T-Mobile US Stock

T-Mobile US Dividend Boost Overshadowed by Major Shareholder Sales

Recommended

Thyssenkrupp Stock

Thyssenkrupp’s Restructuring Plan Faces Critical Test

1 week ago
Almonty Stock

Almonty’s Strategic Pivot: From Defense to Fusion Energy

2 months ago
Stride Stock

Stride Faces Investor Backlash Following Platform Failure

4 months ago
Finance_Commercial (2)

Cadre Holdings Announces Public Offering of Common Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest

Salesforce Shares Face Pressure from External AI Innovation

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

Trending

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

by Rodolfo Hanigan
March 25, 2026
0

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off...

Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026
IBM Stock

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Coeur Mining Stock

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Rebuke Sends ImmunityBio Shares Tumbling
  • Realty Income’s Strategic Financing Defies High Interest Rate Environment
  • IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com